Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Century Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 36 | 49 | +13 |
| Shares | 16.9M | 19.8M | +2.92M (+17.3%) |
| Value | $490.8M | $496.2M | +$5.38M (+1.1%) |
New holders (26)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (13)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| SB Management Ltd | 2,000,000 | $58.7M |
| Eversept Partners, LP | 100,901 | $2.96M |
| Sphera Funds Management Ltd. | 80,000 | $2.35M |
| Monashee Investment Management LLC | 60,000 | $1.76M |
| Goldman Sachs Group Inc | 52,808 | $1.55M |
| Maven Securities LTD | 48,483 | $1.45M |
| LMR Partners LLP | 49,323 | $1.45M |
| Pinz Capital Management, LP | 38,500 | $1.13M |
| Susquehanna International Group, LLP | 23,001 | $675.0K |
| Qube Research & Technologies Ltd | 19,979 | $586.0K |
| Wellington Management Group LLP | 16,821 | $494.0K |
| Norges Bank | 10,000 | $293.0K |
| Tudor Investment Corp Et Al | 7,000 | $205.0K |